Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02335411 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) |
| First Submitted : | January 7, 2015 |
| First Submitted that Met QC Criteria : | January 7, 2015 |
| First Posted : | January 9, 2015 (Estimate) |
| Results First Submitted : | July 13, 2022 |
| Results First Submitted that Met QC Criteria : | July 13, 2022 |
| Results First Posted : | August 8, 2022 |
| Last Update Submitted that Met QC Criteria : | July 13, 2022 |
| Last Update Posted : | August 8, 2022 |